BioVendor Group at EANM 2026: Advancing Nuclear Medicine through collaboration
BioVendor Group at EANM 2026
BioVendor Group is pleased to announce its participation in the EANM Annual Congress 2026, one of the world's leading events dedicated to nuclear medicine, molecular imaging, and theranostics.
Each year, EANM brings together healthcare professionals, researchers, clinicians, and industry experts from around the globe to exchange knowledge, discover the latest scientific advances, and explore innovations shaping the future of personalized medicine.
As a global provider of diagnostic solutions, BioVendor Group remains committed to supporting the scientific and medical communities through innovation, quality, and collaboration. By bringing together the expertise of its companies, including DiaSource, BioVendor Group offers a comprehensive portfolio of diagnostic solutions supporting laboratories, hospitals, and research institutions worldwide.
The congress provides a valuable opportunity to strengthen existing partnerships, connect with new collaborators, and discuss the evolving needs of the nuclear medicine community.
- Dates: October 17-21
- Venue:
Austria Center Vienna (ACV)
Bruno-Kreisky-Platz 1
1220 Vienna -
Visit us at Booth #420 within the Belgian AWEX Pavilion
Representatives from BioVendor Group, including colleagues from DiaSource, will be present throughout the congress and will be delighted to welcome visitors, discuss their projects, and share insights into our portfolio of diagnostic and immunoassay solutions.
Meet our team:
Whether you are looking to explore new collaboration opportunities, learn more about our solutions, or simply exchange ideas with our team, we look forward to meeting you at Booth#420 !
Join us at EANM 2026 and discover how BioVendor Group continues to support innovation in diagnostics and nuclear medicine worldwide.
